406 related articles for article (PubMed ID: 12568499)
21. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
22. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD.
Tagaya E; Yagi O; Sato A; Arimura K; Takeyama K; Kondo M; Tamaoki J
Pulm Pharmacol Ther; 2016 Aug; 39():81-4. PubMed ID: 27350218
[TBL] [Abstract][Full Text] [Related]
23. Rationale of airway clearance.
Clarke SW
Eur Respir J Suppl; 1989 Jul; 7():599s-603s. PubMed ID: 2679608
[TBL] [Abstract][Full Text] [Related]
24. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
25. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
26. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
27. The airway pathophysiology of COPD: implications for treatment.
RodrÃguez-Roisin R
COPD; 2005 Jun; 2(2):253-62. PubMed ID: 17136952
[TBL] [Abstract][Full Text] [Related]
28. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
29. Management of mucus hypersecretion.
Clarke SW
Eur J Respir Dis Suppl; 1987; 153():136-44. PubMed ID: 3322858
[TBL] [Abstract][Full Text] [Related]
30. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
31. Mucoactive drugs for asthma and COPD: any place in therapy?
Rogers DF
Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
[TBL] [Abstract][Full Text] [Related]
32. A view on imaging in drug research and development for respiratory diseases.
van Echteld CJ; Beckmann N
J Pharmacol Exp Ther; 2011 May; 337(2):335-49. PubMed ID: 21317353
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacological treatment of COPD and future of anti-inflammatory therapy].
Watz H; Bitter-Suermann S; Kanniess F; Magnussen H
Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484
[TBL] [Abstract][Full Text] [Related]
34. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
Willke RJ; Burke LB; Erickson P
Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
[TBL] [Abstract][Full Text] [Related]
36. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
Cazzola M; Floriani I; Page CP
Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
[TBL] [Abstract][Full Text] [Related]
38. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
39. Mucoactive medications and airway disease.
Majima Y
Paediatr Respir Rev; 2002 Jun; 3(2):104-9. PubMed ID: 12297055
[TBL] [Abstract][Full Text] [Related]
40. Designing clinical trials to evaluate mucus clearance therapy.
Rubin BK
Respir Care; 2007 Oct; 52(10):1348-58; discussion 1358-61. PubMed ID: 17894903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
